CXCL2

C-X-C motif chemokine ligand 2, the group of Chemokine ligands

Basic information

Region (hg38): 4:74097040-74099196

Previous symbols: [ "GRO2" ]

Links

ENSG00000081041 ∙ NCBI:2920 ∙ OMIM:139110 ∙ HGNC:4603 ∙ Uniprot:P19875 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CXCL2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CXCL2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous						0
missense			8	2		10
nonsense						0
start loss						0
frameshift						0
inframe indel						0
splice donor/acceptor (+/-2bp)						0
splice region						0
non coding						0
Total	0	0	8	2	0

Variants in CXCL2

This is a list of pathogenic ClinVar variants found in the CXCL2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
4-74098622-A-C		not specified	Uncertain significance (Aug 05, 2024)
4-74098643-G-A		not specified	Uncertain significance (Aug 01, 2024)
4-74098683-C-T		not specified	Uncertain significance (Apr 09, 2024)
4-74098874-T-C		not specified	Uncertain significance (Apr 17, 2024)
4-74099033-G-A		not specified	Uncertain significance (Dec 01, 2022)
4-74099033-G-C		not specified	Uncertain significance (Mar 28, 2023)
4-74099036-T-C		not specified	Likely benign (Nov 20, 2024)
4-74099071-C-G		not specified	Uncertain significance (Jan 09, 2024)
4-74099081-G-C		not specified	Uncertain significance (Mar 07, 2025)
4-74099099-C-T		not specified	Likely benign (Jan 29, 2024)
4-74099101-G-T		not specified	Uncertain significance (Dec 25, 2024)
4-74099114-G-C		not specified	Uncertain significance (Nov 15, 2024)

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
CXCL2	protein_coding	protein_coding	ENST00000508487	4	2259

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
3.61e-7	0.0583	125742	0	6	125748	0.0000239

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	-0.0992	53	51.0	1.04	0.00000240	663
Missense in Polyphen		16	16.818	0.95138		219
Synonymous	-1.30	31	23.0	1.35	0.00000120	231
Loss of Function	-1.38	8	4.76	1.68	2.02e-7	57

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.0000615	0.0000615
Ashkenazi Jewish	0.00	0.00
East Asian	0.00	0.00
Finnish	0.00	0.00
European (Non-Finnish)	0.0000176	0.0000176
Middle Eastern	0.00	0.00
South Asian	0.0000654	0.0000653
Other	0.000163	0.000163

dbNSFP

Source: dbNSFP

• Function: FUNCTION: Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity. {ECO:0000269|PubMed:10725737}.
• Pathway: Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human);Salmonella infection - Homo sapiens (human);Legionellosis - Homo sapiens (human);TNF signaling pathway - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);IL-17 signaling pathway - Homo sapiens (human);NF-kappa B signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Spinal Cord Injury;Photodynamic therapy-induced NF-kB survival signaling;Lung fibrosis;Interleukin-10 signaling;Cytokines and Inflammatory Response;Signaling by GPCR;Signal Transduction;Chemokine receptors bind chemokines;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

• pRec: 0.533

Haploinsufficiency Scores

• pHI: 0.0701
• hipred: N
• hipred_score: 0.112

Essentials

• essential_gene_CRISPR: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: N
• gene_indispensability_score: 0.101

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Cxcl1
• Phenotype: cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan)

Gene ontology

• Biological process: response to molecule of bacterial origin;chemotaxis;inflammatory response;immune response;G protein-coupled receptor signaling pathway;regulation of signaling receptor activity;cytokine-mediated signaling pathway;neutrophil chemotaxis;leukocyte chemotaxis;antimicrobial humoral immune response mediated by antimicrobial peptide;chemokine-mediated signaling pathway;cellular response to lipopolysaccharide
• Cellular component: extracellular region;extracellular space
• Molecular function: protein binding;chemokine activity